What Is Toradol and Why Does Access to It During IV Therapy Matter

Toradol is one of those medications that people in acute pain have either never heard of or swear by. If you have ever had it administered in an emergency department for a migraine or a muscle injury, you probably already know what it can do. For everyone else, here is a straightforward explanation of what it is, how we use it at Hyndford Hydration, and why having clinical access to it during a mobile IV session is a meaningful differentiator.

What Toradol Actually Is

Toradol is the brand name for ketorolac tromethamine, a non-steroidal anti-inflammatory drug with potent analgesic properties. Unlike most NSAIDs, which are primarily anti-inflammatory, ketorolac was developed specifically for pain management and produces analgesia comparable to moderate opioid doses without the opioid-associated risks of respiratory depression, dependence, or sedation (Mahmoodi et al., 2024).

It works by inhibiting prostaglandin synthesis, thereby reducing the inflammatory signalling that drives both pain and associated symptoms such as nausea. The intramuscular route achieves rapid absorption with peak plasma concentrations typically within 45 to 60 minutes of administration.

At Hyndford Hydration, Toradol is administered intramuscularly only. IV administration is not authorized under our medical directive. This is consistent with its use in many clinical settings, where IM delivery is preferred for acute pain management outside surgical or critical care contexts.

What the Evidence Supports

Ketorolac has a well-established evidence base across several acute pain presentations.

For migraine, a 2022 systematic review and meta-analysis of 13 randomized controlled trials found that parenteral ketorolac was effective for acute migraine headache management, with efficacy comparable to phenothiazines and metoclopramide, and potentially better pain control than sumatriptan and dexamethasone in limited direct comparisons (Nurathirah et al., 2022). It is used routinely in emergency departments for this indication. The StatPearls clinical reference, updated in February 2024, lists migraine, musculoskeletal pain, and sickle cell crises as established emergency department indications for ketorolac (Mahmoodi et al., 2024).

For acute musculoskeletal pain, ketorolac has been shown to be non-inferior to opioids across multiple studies examining traumatic and non-traumatic musculoskeletal pain, renal colic, and acute pain presentations, with a more favourable side effect profile for most clients (CEEM Journal, 2025).

For dysmenorrhoea, NSAIDs as a class have the strongest evidence base of any pharmacological approach to primary dysmenorrhoea, with a Cochrane review of 80 randomized controlled trials establishing their effectiveness for menstrual pain management (Marjoribanks et al., 2015). Ketorolac IM delivers this effect at a faster onset than oral NSAIDs, which is clinically relevant when pain is already established, and oral absorption is unreliable.

How We Use It at Hyndford Hydration

Toradol is available as an add-on to any IV infusion or as a standalone IM injection, administered only on clinical assessment.

It is not something you book in advance as a fixed service. Your nurse assesses your presentation on arrival, reviews your health history and current medications, confirms there are no contraindications, and makes a clinical decision based on what is in front of them. If Toradol is appropriate for your situation, it can be administered during your visit.

The presentations where it is most commonly relevant include acute migraine, particularly in combination with our Pacific Reset infusion, which addresses the magnesium deficit and fluid component alongside direct pain management. Post-athletic pain and acute musculoskeletal pain following physical exertion or injury. Hangover-related pain and myalgia. Dysmenorrhoea. General acute pain assessed on presentation.

Combining Toradol with Pacific Reset for migraine is worth noting specifically. Magnesium has one of the strongest evidence bases for migraine frequency and severity among nutrient supplements, which we cover in our magnesium post. Administering magnesium intravenously alongside ketorolac IM addresses both the underlying physiological component and the acute pain presentation simultaneously, which is a more comprehensive approach than either intervention alone.

Why This Matters for a Mobile Service

Most wellness IV providers cannot offer this. A nurse working without a valid medical directive and NP oversight does not have access to prescription medications. Access to Toradol under clinical oversight is a direct consequence of having a properly structured medical directive and a regulated nursing team.

For clients managing migraine, acute pain, or dysmenorrhoea, the difference between a provider who can offer clinical pain support and one who cannot is not a small one. Particularly when you are already in pain, and the last thing you can manage is travelling anywhere.

What It Is Not

Under our medical directive, Toradol is used for acute pain management based on clinical assessment. It is not a treatment for chronic pain conditions, and its availability at Hyndford Hydration does not replace ongoing pain management through your GP or specialist. The contraindication list for ketorolac is meaningful and includes active or historical GI ulcers or bleeding, NSAID or aspirin hypersensitivity, anticoagulant use, significant renal impairment, active cardiovascular disease, and pregnancy, among others. Your nurse reviews all of these before any administration.

Ketorolac is also not appropriate for repeated use over extended periods. Our protocol limits use to a maximum of two consecutive days per acute episode, consistent with established clinical guidelines on safe ketorolac administration.

If your pain is medically significant, persistent, or undiagnosed, the appropriate first step is assessment by your GP. Toradol at Hyndford Hydration is for acute pain presentations in clients for whom the clinical picture is clear, and contraindications have been ruled out.

IV and IM therapy is supportive in nature. We do not diagnose or treat medical conditions, and we will not claim to do so.

All sessions are delivered to your door with no mandatory consultation fees for most clients. Clinical screening is completed before every visit under a valid BC medical directive. Travel is included within our Nanaimo service area. Outside Lantzville to Cedar? Get in touch for a travel quote.

Have a look at our Signature Infusions or get in touch with questions.

Ready? Reserve your infusion today.

References

Canadian Agency for Drugs and Technologies in Health. (2014). Ketorolac for pain management: A review of the clinical evidence. https://www.ncbi.nlm.nih.gov/books/NBK254117/

CEEM Journal. (2025). Ketorolac versus other analgesics for acute pain: A systematic review. https://www.ceemjournal.org/upload/pdf/ceem-25-002.pdf

Mahmoodi, A. N., Patel, P., & Kim, P. Y. (2024). Ketorolac. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK545172/

Marjoribanks, J., Ayeleke, R. O., Farquhar, C., & Proctor, M. (2015). Nonsteroidal anti-inflammatory drugs for dysmenorrhoea. Cochrane Database of Systematic Reviews. https://www.cochrane.org/evidence/CD001751

Nurathirah, M. N., Yazid, M. B., Norhayati, M. N., Baharuddin, K. A., & Abu Bakar, M. A. (2022). Efficacy of ketorolac in the treatment of acute migraine attack: A systematic review and meta-analysis. Academic Emergency Medicine, 29(9), 1118-1131.